speb/financial-data huggingface dataset:
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 22920000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -161000.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ASCU.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 29032000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 1183000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1259000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 119000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 9798000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 151531685.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 31440000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7861000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 32000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 188310000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 58681000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 58681000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 58681000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 35796000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -7861000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -107000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -972000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 58000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 0.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -914000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 27827000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 188310000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 154700000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 35678000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 28000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10914000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 59368000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 32000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 32000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 13479000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 43000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 10000000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 151531685.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — EBIT: -234000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — EBITDA: -191000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -586000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 58681000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 35796000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -7968000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 856000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 131877000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Gross Profit: -28000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 69000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 69000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Interest Income: 226000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 226000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 154700000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -7861000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 35678000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -16000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 35678000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 586000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -303000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -303000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 988000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -16000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -16000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 988000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 131877000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -7861000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 154700000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1455000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -191000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -303000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -107000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 586000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Operating Income: -1211000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 174631722.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 568000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1200000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 252000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -80000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 149000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 11611000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -80000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 74000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 131877000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Payables: 1333000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 12247000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -303000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 134000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7861000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 119000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 28000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 43000.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -16000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -43408000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 604000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 327000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1183000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 174631722.00
ASCU.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 332000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 154700000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 154700000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 191245000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 154700000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 32000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 154700000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 1211000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 36545000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 131877000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 23066000.00
ASCU.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -831000.00
ASCU.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 45889000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 1372000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2641000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 151000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -243000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 9854000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 178255638.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
ASCU.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 58681000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -24551000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 195908000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 44370000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 44370000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 44370000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 7353000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -21361000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -112000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1857000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -21000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 0.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1836000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -14119000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 195908000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 159574000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7107000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: -15000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1259000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 45110000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9972000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: -38000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 10000000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 178255638.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
ASCU.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — EBIT: -1439000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — EBITDA: -1439000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -192000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 44370000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 7353000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -24663000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 988000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 102515000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 131690000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 15000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 1049000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1049000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Interest Income: 300000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 300000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 159574000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -21361000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7107000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 340000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 7107000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 192000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2488000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2780000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2488000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -749000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -16000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -16000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -749000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 131447000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -21343000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 57059000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1586000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1439000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -2488000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -112000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 192000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Operating Income: -1357000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 179712984.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 589000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 5935000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 276000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -382000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 102515000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 392000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 97940000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -382000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 121000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 131350000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Payables: 2762000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4021000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -2488000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 262000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -24533000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 151000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: -15000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: -38000.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -46188000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 712000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 384000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1372000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 179712984.00
ASCU.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 286000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 159574000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 57059000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 279072000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 159574000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 16000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 159574000.00
ASCU.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 1357000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 119498000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 233962000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 109526000.00
ASCU.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 35138000.00
ASCU.TO income_statement (annual, 2025-12-31) — +Operating Expense: 7601000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 3567000.00
ASCU.TO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
ASCU.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 1325000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1325000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 772000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 772000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -261000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -261000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 10074000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 10074000.00
ASCU.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 165727134.00
ASCU.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.03
ASCU.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 31741000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 44370000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -50635000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2953000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 57000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 57000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 262244000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 262244000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 104754000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 104754000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 104754000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 104754000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 104754000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 104754000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 121510000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 63392000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -50635000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6143000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1465000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3021000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 3886000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Payable: 3886000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 3886000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2482000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -410000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 9000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -649000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -649000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 2827000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1842000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 72340000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 60270000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Common Stock: 262244000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 262244000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 225837000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 225837000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 120821000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 63051000.00
ASCU.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 31000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 18000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4720000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4720000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Current Assets: 106106000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 106106000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 57000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 57000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 57000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 57000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 27225000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 27225000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 31000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 21000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
ASCU.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 165727134.00
ASCU.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.03
ASCU.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — EBIT: -4000000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — EBIT: 143000.00
ASCU.TO income_statement (annual, 2025-12-31) — EBITDA: -3969000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — EBITDA: 164000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 673000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 114000.00
ASCU.TO cash_flow (annual, 2025-12-31) — End Cash Position: 104754000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 104754000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 121510000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 63392000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -49170000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 68000.00
ASCU.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 5871000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2997000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 104274000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 104274000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 137853000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 137853000.00
ASCU.TO income_statement (annual, 2025-12-31) — Gross Profit: -31000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Gross Profit: -18000.00
ASCU.TO income_statement (annual, 2025-12-31) — Interest Expense: 965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 436000.00
ASCU.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 436000.00
ASCU.TO income_statement (annual, 2025-12-31) — Interest Income: 1065000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Interest Income: 247000.00
ASCU.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1065000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 247000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 225837000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 225837000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -50635000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -6143000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 120821000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 63051000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -59000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -11000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 340000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 340000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 120821000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 63051000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -673000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -114000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -293000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -4965000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -293000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Interest Income: 1409000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 1120000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -59000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -11000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -59000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -11000.00
ASCU.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1409000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1120000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Net PPE: 137592000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 137592000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -50635000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -6161000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 121563000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 121563000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2490000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2490000.00
ASCU.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -7045000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 164000.00
ASCU.TO income_statement (annual, 2025-12-31) — Normalized Income: -8041000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -293000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1465000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3021000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -673000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -114000.00
ASCU.TO income_statement (annual, 2025-12-31) — Operating Income: -7632000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Operating Income: -3585000.00
ASCU.TO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 208656359.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 208656359.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 580000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 580000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 20771000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 20771000.00
ASCU.TO income_statement (annual, 2025-12-31) — Other Gand A: 760000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 206000.00
ASCU.TO income_statement (annual, 2025-12-31) — Other Income Expense: 1258000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 2172000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 104274000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 104274000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2872000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1664000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 92420000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 92420000.00
ASCU.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1818000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -904000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Payable: 352000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 352000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Other Properties: 137513000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 137513000.00
ASCU.TO income_statement (annual, 2025-12-31) — Other Special Charges: -2996000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Payables: 1677000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Payables: 1677000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6397000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6397000.00
ASCU.TO income_statement (annual, 2025-12-31) — Pretax Income: -4965000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -293000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 748000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 352000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -50635000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2971000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Receivables: 772000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 772000.00
ASCU.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 31000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 18000.00
ASCU.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 31000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 21000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -59000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -11000.00
ASCU.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -80000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -46481000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -46481000.00
ASCU.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 5111000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 2791000.00
ASCU.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1730000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 570000.00
ASCU.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 7601000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3567000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Share Issued: 208656359.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 208656359.00
ASCU.TO income_statement (annual, 2025-12-31) — Special Income Charges: 3076000.00
ASCU.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1373000.00
ASCU.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -99000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 225837000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 225837000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 121563000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 121563000.00
ASCU.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ASCU.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Assets: 347972000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 347972000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 225837000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 225837000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Debt: 57000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 57000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 225837000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 225837000.00
ASCU.TO income_statement (annual, 2025-12-31) — Total Expenses: 7632000.00
ASCU.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 3585000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 122135000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 122135000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 241866000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 241866000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 94910000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 94910000.00
ASCU.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: -1309000.00
ASCU.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 3076000.00
ASCU.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3076000.00
ASCU.TO balance_sheet (annual, 2025-12-31) — Working Capital: 78881000.00
ASCU.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 78881000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 9032000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4575000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 227000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -274000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 10112000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 208670240.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.12
ASCU.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 104754000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -8269000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 42000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 262984000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 80893000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 80893000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 80893000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -14443000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8269000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -889000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 6219000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 90000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 545000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 6854000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -23601000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 262984000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 201753000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 13000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2213000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 81610000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 42000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 42000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 38536000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 0.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 208670240.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.12
ASCU.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — EBIT: -24856000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — EBITDA: -24856000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -260000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 80893000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -14443000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -9158000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 8408000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 106212000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 145937000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Gross Profit: -13000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 6000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Interest Income: 843000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 843000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 201753000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -8269000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -16000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 340000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 260000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -24862000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -24862000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 837000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -16000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -16000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 837000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -15000000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 145663000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -8269000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 95541000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3585000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -9297000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -9303000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -889000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 260000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Operating Income: -9045000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 209007925.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 490000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 25893000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 2203000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -16654000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 106212000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 16654000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 89611000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1095000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 5813000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 145597000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Other Special Charges: 15559000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Payables: 10388000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 12601000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -24862000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 573000.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -8269000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 227000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 13000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 0.00
ASCU.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -16000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -71343000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 6205000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 624000.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9032000.00
ASCU.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 209007925.00
ASCU.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -15559000.00